• Skip to primary navigation
  • Skip to main content
Welcome

Chapkin Lab Home

Chapkin Lab

  • People
    • Dr. Chapkin Biography
    • CHAPKIN LAB RESEARCH STAFF
      • Meet Dr. Laurie Davidson
      • Meet Dr. Alfredo Erazo-Oliveras
      • Meet Dr. Yang-Yi Fan
      • Meet Jennifer Goldsby
      • Meet Dr. Monica Muñoz Vega
      • Meet Jaileen Rivera-Rodriguez
      • Meet Kristen Frederick
      • Meet Lexi Poston
    • CHAPKIN LAB POST-DOCTORAL RESEARCHERS
      • Meet Dr. Michael Salinas
      • Meet Dr. Vanessa Montoya Uribe
      • Meet Dr. Selim Romero
      • Meet Dr. Pritam Dey
    • CHAPKIN LAB GRADUATE STUDENTS
      • Meet Destiny Mullens
    • CHAPKIN LAB UNDERGRADUATE STUDENTS
      • Meet Jennie P. Kim
      • Meet Bailee McEwan
    • CHAPKIN LAB ADMINISTRATOR
      • Meet Ms. Elizabeth Toole Szymanski
  • News
  • Research
    • NR4A1 & Arylhydrocarbon Receptor Biology
    • Gut Stem Cell Biology
    • Host-Microbe Interactions in the Human Gut
    • Membrane Therapy
  • Publications
  • CPRIT/TREC Single Cell Core
    • Single Cell Data Science Core & Chapkin Lab
    • Events with the SCDS Core Team
    • Events Sponsored by Texas A&M University Regional Center of Excellence in Cancer Research (TREC)
    • Single Cell Data Science Core – Recently Published Research
  • Lab Funding
    • Nutritional and clinical predictors of intestinal maturation and feeding tolerance in the preterm infant
    • Targeting plasma membrane spatial dynamics to suppress aberrant Wnt signaling
    • NR4A1 antagonists inhibit colorectal cancer growth and enhance immune surveillance
    • Bayesian differential causal network and clustering methods for single-cell data
    • The selective advantage of mismatch repair loss in colonic stem cells
    • Mediterranean diet and weight loss: Targeting the bile acid/gut microbiome axis to reduce colorectal cancer risk
    • Dietary and microbial predictors of childhood obesity risk
    • Diet and the colonic exfoliome: A novel, non-invasive approach to testing interventions in humans
    • Gene – environment – lifestyle interactions in cancer
  • William W. Allen Endowed Chair
  • Gallery
  • Job Opportunities
  • Contact
  • Show Search
Hide Search
You are here: Home / Archives for Lab News

Lab News

$1.19 million grant will leverage single-cell sequencing technology: National Institutes of Health-funded project will help with cancer diagnosis, treatment, prevention

Elizabeth Szymanski · February 2, 2023 ·

 

$1.19 million grant will leverage single-cell sequencing technology

The Texas A&M University System has received a $1.19 million grant from the National Institutes of Health, NIH, for a multidisciplinary collaboration to study the intricate connections between genomics, nutrition and health. Understanding these connections will help in the diagnosis and treatment of cancer and other diseases.

Head and shoulder of an oriental man, Yang Ni, Ph.D., Department of Statistics in Texas A&M's College of Arts and Sciences
Yang Ni, Ph.D., associate professor in the Department of Statistics at Texas A&M’s College of Arts and Sciences, is the primary investigator for “Bayesian differential causal network and clustering methods for single-cell data.” (Courtesy photo)

Yang Ni, Ph.D., an assistant professor in the College of Arts and Sciences Department of Statistics, will be the principal investigator for the effort. The project, which aims to create a toolset for interpreting and correlating novel genetic information, is titled “Bayesian differential causal network and clustering methods for single-cell data.”

Co-investigators for the project will be Robert Chapkin, Ph.D, Distinguished Professor and Allen Endowed Chair in the College of Agriculture and Life Sciences Department of Nutrition and Department of Biochemistry and Biophysics, and James Cai, Ph.D., associate professor in the School of Veterinary Medicine and Biomedical Sciences Department of Veterinary Integrative Biosciences.

The project aims to advance single-cell data science, the study of how genes and gene expression differ among individual cells in one organism. Because cancer arises from genetic abnormalities in individual cells, scientists believe that single-cell data science will reveal medically important information.

This NIH award is tied to a pending grant to the Cancer Prevention and Research Institute of Texas, CPRIT, to assess gene-environment-lifestyle interactions in cancer. Chapkin is spearheading that effort in collaboration with Ken Ramos, M.D., Ph.D., executive director at Texas A&M’s Institute of Biosciences and Technology.

Ramos and Chapkin have also submitted a $6 million grant titled “Gene-environment-lifestyle interactions in cancer” to the CPRIT to create a new regional center of excellence in cancer research.

Chapkin said the NIH grant’s goals and personnel will complement the establishment of a single-cell data science core at Texas A&M that will serve as a shared-resource facility.

Purpose and goals of single-cell technology

The emergence of new technologies such as single-cell RNA sequencing and spatial profiling has brought about many methods to study gene regulation and cell differentiation in the single cells of multicellular organisms.

Ni will lead the effort, along with students and postdocs, to develop and implement new statistical methods for discovering causal gene regulation and molecular cell types with single-cell RNA-sequencing data.

“We will also work closely with Drs. Chapkin and Cai to solve real-world biological and biomedical problems,” he said.

“New methods are required to compare molecular differences at the single-cell level, so we can translate the knowledge advanced by single-cell RNA sequencing and spatial mapping to improve disease diagnosis, treatment and prevention,” Ni said.

 A balding man, Dr. Robert Chapkin , sitting in his laboratory looking through a microscope
Robert Chapkin, Ph.D., is one of the co-principal investigators for the single-cell technology and high-throughput genomic sequencing project. (Texas A&M AgriLife photo by Laura McKenzie)

Single-cell technology and high-throughput sequencing have enabled entirely new realms of biology, such as “deep phenotyping” and personalized medicine.

“In these applications, big data provide insights into cures for various diseases, including cancer,” Chapkin said.

Single-cell data allows for the detection of cell-to-cell interactions, gene networks and the spatial organization of gene expression in tissue samples.

“There is a consensus that single-cell multiomics data, in which data sets of different groups are combined during analysis, and spatial information will be driving next-generation solutions in oncology,” Chapkin said.

He said this type of single-cell multiomic research, is highly innovative.

“It will enable the characterization of previously unapproachable clinical phenomena, such as ’deep landscapes’ of cancer heterogeneity that will reveal more about the dynamics of the tumor microenvironment,” Chapkin said.

Ni said a long-term goal of the project is to develop novel statistical methods for generating and evaluating new hypotheses about complex cellular processes across disparate sample groups, such as disease subtypes and treatment groups.

Specifically, Ni said the team will work to design and validate Bayesian network and clustering models. The novel statistical models and related analytical tools will help accurately describe changes in gene regulation and cell differentiation in response to experimental interventions at the single-cell level under different experimental conditions.

“Without such tools, mechanistically understanding gene regulatory activities and cell differentiation will likely remain difficult,” he said. “And the proposed methods would be widely applicable to a range of data generated under different experimental conditions, disease subtypes and treatment groups.”

Single-cell modeling and connecting

Graphic of how single-cell RNA sequencing and spatial mapping can be used to develop "deep phenotyping" - keywords on the graphic are Cancer, Therapeutics, Tumor, Microenvironment, T cell exhaustion, Cancer stem cells, Single cells, Metabolomics (small molecultes), Trancsriptomics (mRNA), Epigenomics (DNA) and Proteomics (proteins)
The project will identify variables and probable relationships using single-cell RNA sequencing data to develop an interface between human genetics, computational statistics and data science. (Graphic courtesy of Robert Chapkin)

A Bayesian network model governs the probability and causal rules of a set of variables. An example would be a Bayesian network representing the probable relationships between diseases and their symptoms.

“In a Bayesian network model, first you identify main variables in the problem you want to solve,” explained Ni. “Then you specify or learn the structure of the network, which is the causal relationships between all the variables identified. After that, you determine the probability rules governing the relationships between those variables.”

Cai is also an affiliated faculty member in the College of Engineering Department of Electrical and Computer Engineering, and the Cai lab members develop analytical frameworks to study single-cell genomics data gathered from various types of cells.

In this project, he will play a bridging and coordinating role by connecting statisticians with molecular biologists to create an interface between human genetics, computational statistics and data science.

Sharing the results

Ni will lead the effort to disseminate the project’s results more broadly through open-source software, conference presentation, graduate and undergraduate education and mentoring, and hosting interdisciplinary workshops and symposia.

“We’re arranging for these workshops to provide travel stipends to help underrepresented students in STEM and encourage their participation,” he noted.

To help prepare next-generation researchers, statisticians and data scientists and improve public statistical literacy and engagement, Ni will also host data science competitions designed to engage undergraduate students.

“I also plan to develop a new graduate course on causal networks, and supervise the research of postdoctoral, graduate and undergraduate researchers,” he said.

Link to AgriLife Today:  https://agrilifetoday.tamu.edu/2022/11/30/1-19-million-grant-will-leverage-single-cell-sequencing-technology/

Personalized Nutrition

· August 29, 2022 ·

Dr. Chapkin presents an invited webinar on “Personalized nutrition using microbial metabolite phenotype to stratify participants”.  This presentation also features a discussion on host exfoliomics (host mRNAs isolated from the fecal stream) that reveal the effects of dietary fiber in a clinical trial.

 

Texas A&M AgriLife Research recognizes outstanding achievers

· July 1, 2021 ·

Research Scientist of the Year Award: Robert Chapkin, Ph.D

Texas A&M AgriLife Research Professor Robert Chapkin, Ph.D., College Station, has made outstanding contributions to the areas of precision nutrition and stem cell biology, cancer chemoprevention and the development of noninvasive predictive biomarkers. Chapkin carries the title of Distinguished Professor in the Texas A&M University Department of Nutrition. He holds the Allen Endowed Chair in Nutrition & Chronic Disease Prevention, and he is a University Faculty Fellow, a Regents Fellow and an AgriLife Senior Faculty Fellow.

His achievements, in concert with innovation in basic research, have propelled Chapkin to securing unprecedented funding from the National Institutes of Health – National Cancer Institute. He serves as the co-director of a major NCI grant to conduct training on nutrition, biostatistics and bioinformatics. He is also an American Association for the Advancement of Science Fellow.

Chapkin has published 271 peer-reviewed manuscripts, 27 book chapters and 305 abstracts, and is listed as co-inventor on three patents. His publications have been cited more than 16,000 times, demonstrating his influence in the fields of nutrition, cancer biology and computational biology.

He has mentored 15 master’s of science degree students and 24 doctoral students in biology, biochemistry and biophysics, nutrition, genetics, toxicology, biotechnology and molecular medicine, all in addition to mentoring 26 post-doctoral fellows.

Visit Chapkin’s profile page with the Texas A&M University Department of Nutrition.

Robert Chapkin in lab portrait
Robert Chapkin, Ph.D.

Researchers target cell membranes for cancer research

· June 10, 2021 ·

“We are pleased to announce the publication of our recent paper on membrane therapy.  The paper is highlighted in the American Society of Biochemistry & Molecular Biology (ASBMB) Today and can now be accessed online”. Fuentes JLR 2021,   Supplemental Material .

“You can read the article about our recent paper in the Journal of Lipid Research using the link below”.

https://www.asbmb.org/asbmb-today/science/060121/researchers-target-cell-membrane-for-cancer-resear 

Press Release with Texas AgriLife Research

cbienek7138 · March 5, 2021 ·

For the last 32 years, Robert Chapkin, Ph.D., Texas A&M Department of Nutrition Distinguished professor, Allen Endowed Chair in Nutrition & Chronic Disease Prevention and National Cancer Institute Outstanding Investigator Award Recipient, College Station, has conducted revolutionary work around noninvasive means of investigating and modeling the role of nutrition in infant development into adulthood. His team’s discovery of what has become known as the “exfoliome,” as well as studies of the gut microbiome in infants, has changed the way in which science investigates nutritional impacts in humans.

The lack of a noninvasive approach to repeatedly access tissue along the intestinal tract has hampered researchers’ ability to study normal gut development and clinical responses to dietary or medical interventions. Thus, Chapkin spearheaded the discovery of the field of noninvasive precision exfoliomics — development of mRNA-based biomarkers using stool derived exfoliated cells shed from the neonatal and adult intestinal tract. This transformative body of work has enabled big-data applications in precision analysis of gut microbe (prokaryotic) and host (eukaryotic) crosstalk in response to diet and chronic disease risk.

Understanding the specifics of gut microbes through advanced phenotyping opens the door to explore precision therapies to improve human health on an individualized basis.

This discovery method has impacted our understanding of neonatal and early childhood development in relation to diet, particularly in studying the effects of breast milk vs. formula. At the same time, it has opened the doors to exploring host-microbe crosstalk and has allowed us to better understand the role diet plays in colon cancer prevention.

The noninvasive approach was used in a previous study to examine diet and microbes as modifiers to stem cell homeostasis and colon cancer in mice. The results demonstrated that long-chain omega-3 fatty acids found in fish oil have synergistic effects when combined with dietary fiber or curcumin, which is found in turmeric, in dramatically reducing colon cancer risk by selectively destroying damaged stem cells through a process called ferroptosis. 

These preclinical findings suggest that a pescatarian vegetarian diet (high in omega-3 fatty acids and fiber) might help lower the risk of colon cancer in humans by destroying cancer stem cells before they have the chance to replicate. This project has since moved to the clinical research stage thanks to a National Institutes of Health (NIH) grant in collaboration with the Fred Hutchison Cancer Center in Seattle, WA. 

 

  • « Go to Previous Page
  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4
  • Go to page 5
  • Interim pages omitted …
  • Go to page 10
  • Go to Next Page »

A member of
Texas A&M AgriLife

Texas A&M AgriLife Extension Service | Texas A&M AgriLife Research | Texas A&M Forest Service | Texas A&M AgriLife Veterinary Medical Diagnostic Lab | College of Agriculture & Life Sciences

Compact with Texans | Privacy and Security | Accessibility Policy | State Link Policy | Statewide Search | Veterans Benefits | Military Families | Risk, Fraud & Misconduct Hotline | Texas Homeland Security | Texas Veterans Portal | Equal Opportunity | Open Records/Public Information

Copyright © Texas A&M AgriLife